Oncogenic role of microRNA-20a in human multiple myeloma

References

• AndersonKCCarrascoRDPathogenesis of myelomaAnnu Rev Pathol2011624927421261519
   PubMed Web of Science ®Google Scholar
• JemalAMurrayTWardECancer statistics, 2005CA Cancer J Clin2005551103015661684
   PubMed Web of Science ®Google Scholar
• RajkumarSVTreatment of multiple myelomaNat Rev Clin Oncol20118847949121522124
   PubMed Web of Science ®Google Scholar
• CalimeriTBattistaEConfortiFA unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cellsLeukemia201125470771121233838
   PubMed Web of Science ®Google Scholar
• TassonePNeriPBurgerRMouse models as a translational platform for the development of new therapeutic agents in multiple myelomaCurr Cancer Drug Targets201212781482222671927
   PubMed Web of Science ®Google Scholar
• SchulerJEwerthDWaldschmidtJWaschREngelhardtMPreclinical models of multiple myeloma: a critical appraisalExpert Opin Biol Ther201313Suppl 1S111S12323742200
   PubMedGoogle Scholar
• TassonePNeriPCarrascoDRA clinically relevant SCID-hu in vivo model of human multiple myelomaBlood2005106271371615817674
   PubMedGoogle Scholar
• TassonePTagliaferriPRossiMChallenging the current approaches to multiple myeloma-related bone disease: from bisphosphonates to target therapyCurr Cancer Drug Targets20099785487020025573
   PubMedGoogle Scholar
• MunshiNCAndersonKCNew strategies in the treatment of multiple myelomaClin Cancer Res201319133337334423515406
   PubMed Web of Science ®Google Scholar
• TassonePTagliaferriPRossiMGaspariMTerraccianoRVenutaSGenetics and molecular profiling of multiple myeloma: novel tools for clinical management?Eur J Cancer200642111530153816820292
   PubMedGoogle Scholar
• PalumboAAndersonKMultiple myelomaN Engl J Med2011364111046106021410373
   PubMed Web of Science ®Google Scholar
• TassonePTagliaferriPFulcinitiMTDi MartinoMTVenutaSNovel therapeutic approaches based on the targeting of microenvironment-derived survival pathways in human cancer: experimental models and translational issuesCurr Pharm Des200713548749617348845
   PubMedGoogle Scholar
• TagliaferriPRossiMDi MartinoMTPromises and challenges of microRNA-based treatment of multiple myelomaCurr Cancer Drug Targets201212783884622671926
   PubMed Web of Science ®Google Scholar
• Di MartinoMTLeoneEAmodioNSynthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidenceClin Cancer Res201218226260627023035210
   PubMed Web of Science ®Google Scholar
• AmodioNDi MartinoMTForestaUmiR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1Cell Death Dis20123e43623190608
   PubMed Web of Science ®Google Scholar
• RossiMPitariMRAmodioNmiR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone diseaseJ Cell Physiol201322871506151523254643
   PubMed Web of Science ®Google Scholar
• LeeRCFeinbaumRLAmbrosVThe C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14Cell19937558438548252621
   PubMed Web of Science ®Google Scholar
• XieXLuJKulbokasEJSystematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammalsNature2005434703133834515735639
   PubMed Web of Science ®Google Scholar
• BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
   PubMed Web of Science ®Google Scholar
• HeLHannonGJMicroRNAs: small RNAs with a big role in gene regulationNat Rev Genet20045752253115211354
   PubMed Web of Science ®Google Scholar
• CalinGALiuCGSevignaniCMicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemiasProc Natl Acad Sci U S A200410132117551176015284443
   PubMed Web of Science ®Google Scholar
• IorioMVFerracinMLiuCGMicroRNA gene expression deregulation in human breast cancerCancer Res200565167065707016103053
   PubMed Web of Science ®Google Scholar
• MarcucciGRadmacherMDMaharryKMicroRNA expression in cytogenetically normal acute myeloid leukemiaN Engl J Med2008358181919192818450603
   PubMed Web of Science ®Google Scholar
• CroceCMCauses and consequences of microRNA dysregulation in cancerNat Rev Genet2009101070471419763153
   PubMed Web of Science ®Google Scholar
• Esquela-KerscherASlackFJOncomirs – microRNAs with a role in cancerNat Rev Cancer20066425926916557279
   PubMed Web of Science ®Google Scholar
• NohataNHanazawaTEnokidaHSekiNmicroRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancersOncotarget20123192122308266
   PubMedGoogle Scholar
• VenturaAYoungAGWinslowMMTargeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clustersCell2008132587588618329372
   PubMed Web of Science ®Google Scholar
• XiongYZhangLKebebewEMiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1PLOS One201495e9610324858712
   PubMed Web of Science ®Google Scholar
• WangZWangBShiYOncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2Oncogene201534111407141924704830
   PubMed Web of Science ®Google Scholar
• LiXZhangZYuMInvolvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2)Int J Mol Sci2013148162261623923924943
   PubMed Web of Science ®Google Scholar
• SchetterAJLeungSYSohnJJMicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinomaJAMA2008299442543618230780
   PubMed Web of Science ®Google Scholar
• ZhaoSYaoDChenJDingNRenFMiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivoPLoS One2015103e012090525803820
   PubMed Web of Science ®Google Scholar
• QiangXFZhangZWLiuQmiR-20a promotes prostate cancer invasion and migration through targeting ABL2J Cell Biochem201411571269127624464651
   PubMed Web of Science ®Google Scholar
• HuangJJYuJLiJYLiuYTZhongRQCirculating microRNA expression is associated with genetic subtype and survival of multiple myelomaMed Oncol20122942402240822447484
   PubMedGoogle Scholar
• TassonePDi MartinoMTVenturaMLoss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivoCancer Biol Ther20098764865319333003
   PubMed Web of Science ®Google Scholar
• NeriPTagliaferriPDi MartinoMTIn vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitorBr J Haematol2008143452053118986388
   PubMedGoogle Scholar
• GrunewaldTGBernardVGilardi-HebenstreitPChimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatelliteNat Genet20154791073107826214589
   PubMedGoogle Scholar
• MatsubaraHTakeuchiTNishikawaEApoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92Oncogene200726416099610517384677
   PubMed Web of Science ®Google Scholar